ASP Isotopes Inc. ASPI

ASPI Company Overview

ASP Isotopes Inc. (NASDAQ: ASPI) is a development-stage advanced materials and isotope enrichment company focused on the production of isotopes for the healthcare, semiconductor, quantum technology, and clean energy industries. The company develops proprietary isotope separation technologies intended to enrich isotopes used in medical diagnostics and therapeutics, advanced semiconductors, nuclear energy applications, and industrial processes. Its primary commercial focus has included isotopes such as carbon-14, silicon-28, ytterbium-176, and molybdenum-100, which have applications across radiopharmaceuticals, quantum computing, and next-generation chip manufacturing.

The company traces its origins to isotope enrichment technology development efforts associated with aerodynamic separation processes. ASP Isotopes has positioned itself as an alternative supplier in isotope markets that have historically been dominated by state-affiliated or limited global producers. The company’s strategy emphasizes lower-cost enrichment technologies, diversification of isotope supply chains, and long-term participation in sectors expected to experience rising isotope demand, particularly nuclear medicine and semiconductor manufacturing.